Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Bifunctional Epoxide Hydrolase 2 (sEH) is an enzyme that possesses both epoxide hydrolase and lipid-phosphate phosphatase activities. It plays a crucial role in regulating the levels of bioactive lipids, particularly epoxides like EETs, which have anti-inflammatory properties. As a drug target, sEH is being explored for various therapeutic areas including cardiovascular disease, pain, and cancer.
Inhibition of epoxide hydrolysis and/or lipid-phosphate dephosphorylation.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bifunctional Epoxide Hydrolase 2 (sEH).